ExoXpert SRL
8.3 FTEThe score of ExoXpert shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ExoXpert's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
ExoXpert's financial analysis
- Solvency-190.2%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ExoXpert
ExoXpert's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1003.807.666
- VAT number
- BE1003807666
- Peppol
- Registered · 0208:1003807666 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Dec 2023
- Registered office
- 4000 Liège
- Size
- Micro · 8.3 FTE
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
ExoXpert (SRL) has been based in Liège since 2023, active in: manufacture of other pharmaceutical products. For 2025, it reports revenue of 42,100 €, a net loss of €1.71m and equity of −€3.90m. With 8.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -190.2%, below the median of its sector (34.4%).
Companies similar to ExoXpert
Companies in the same business, of comparable size and area, outside its group.
- Alnylam Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet €1.20m
- Groovy.Bio Manufacture of pharmaceutical preparations Evergem · balance sheet 744,069 €
- Phoenix Biosciences Manufacture of pharmaceutical preparations Nivelles · balance sheet €8.11m
- Etherna Immunotherapies Research and experimental development on natural sciences and engineering Niel · balance sheet €12.8m
- White Raven Manufacture of pharmaceutical preparations Liège · balance sheet €9.55m
- ATB Therapeutics Manufacture of basic pharmaceutical products Marche-en-Famenne · balance sheet €10.6m
- Cellistic Manufacture of pharmaceutical preparations Mont-Saint-Guibert · balance sheet €41.6m
- ConvEyXo Research and experimental development on natural sciences and engineering Charleroi · balance sheet €10.3m
Frequently asked questions about ExoXpert
What is the revenue of ExoXpert?
According to the 2025 annual accounts filed with the NBB, the revenue of ExoXpert amounts to 42,100 €.
What is the VAT number of ExoXpert?
In Belgium, the VAT number is the company number prefixed with BE: BE1003807666 for ExoXpert, if the company is VAT-registered. Its company number (CBE) is 1003.807.666.
Where is the registered office of ExoXpert?
According to the CBE register, the registered office of ExoXpert is in 4000 Liège.
What is the equity of ExoXpert?
At the close of the 2025 financial year, the equity of ExoXpert amounts to -3,900,147 €, a solvency of -190.2% of total assets.
How many people work at ExoXpert?
8.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ExoXpert?
The register lists 2 active mandates at ExoXpert. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ExoXpert
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →